Peptide Therapy Clinical-Grade Compounds
Professional-grade peptide compounds for clinical applications. Sourced from state-licensed compounding pharmacies with full chain-of-custody documentation, sterility testing, and Certificates of Analysis for every batch.
FDA Compounding Disclaimer These compounded medications are not FDA-approved. They are prepared by state-licensed compounding pharmacies under 503A/503B regulations. All compounds are dispensed pursuant to valid prescriptions from licensed healthcare providers.
Peptide therapy formulary
BPC-157
Body Protection Compound-157. Research peptide used in clinical regenerative protocols.
PT-141 (Bremelanotide)
Melanocortin receptor agonist. Individualized dosing protocols available.
Sermorelin
Growth hormone releasing hormone (GHRH) analogue. Often used in combination protocols.
CJC-1295/Ipamorelin
Dual-peptide combination. CJC-1295 (GHRH analogue) paired with Ipamorelin (GHRP) for synergistic GH release.
PCAB-Accredited Sourcing. Full Documentation.
All peptide compounds are sourced from PCAB-accredited and state-licensed compounding pharmacies. Every batch includes a Certificate of Analysis (CoA), sterility testing documentation, and chain-of-custody records. Veridian Health continuously monitors pharmacy credentials, accreditation status, and regulatory compliance so your clinic doesn't have to.
Ready to add peptide therapy to your practice?
Apply for provider access to view full pricing, place orders, and connect with our verified pharmacy network for clinical-grade peptide compounds.
Apply for Provider Access →